Vallon Pharmaceuticals (NASDAQ:VLON – Get Rating) and Evelo Biosciences (NASDAQ:EVLO – Get Rating) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their institutional ownership, dividends, analyst recommendations, profitability, risk, valuation and earnings. Valuation & Earnings This table compares Vallon Pharmaceuticals and […]
Olema Pharmaceuticals (NASDAQ:OLMA – Get Rating) and Vallon Pharmaceuticals (NASDAQ:VLON – Get Rating) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, risk, institutional ownership, profitability, earnings, dividends and valuation. Insider and Institutional Ownership 5.6% of Vallon Pharmaceuticals shares […]
Vallon Pharmaceuticals, Inc. (NASDAQ:VLON – Get Rating) was the target of a significant growth in short interest in May. As of May 31st, there was short interest totalling 117,800 shares, a growth of 33.6% from the May 15th total of 88,200 shares. Based on an average daily volume of 3,500,000 shares, the short-interest ratio is […]
Vallon Pharmaceuticals (NASDAQ: VLON – Get Rating) is one of 930 public companies in the “Pharmaceutical preparations” industry, but how does it compare to its rivals? We will compare Vallon Pharmaceuticals to similar companies based on the strength of its risk, valuation, earnings, profitability, dividends, institutional ownership and analyst recommendations. Insider & Institutional Ownership 5.6% […]